靠谱棋牌网站
Home
CytoCares
Technology Platform
TriTE
TM
Platform
CCNK
TM
Platform
CCMφ
TM
Platform
Pipeline
News Center
Company News
Industry Information
Join Us
Contact Us
简体中文
English
Home
CytoCares
Technology Platform
TriTE
TM
Platform
CCNK
TM
Platform
CCMφ
TM
Platform
Pipeline
News Center
Company News
Industry Information
Join Us
Contact Us
中文
English
News Center
Company News
Industry Information
Home
>
News Center
News Center
News Center
Learn More >
Company News
2023-08-07
靠谱棋牌网站生物三抗CC312的临床I期研究完成首例患者首次给药
2023-07-14
靠谱棋牌网站生物受邀参加IBI EXPO 2023 国际生物创新药产业大会
2023-07-07
靠谱棋牌网站生物CC312冻干粉针剂临床研究启动会顺利举行
Learn More >
Industry Information
2022-05-23
靠谱棋牌网站生物首个三抗药物获FDA批准进入临床，CD3/CD28共刺激信号三抗备受关注
2022-02-26
赛诺菲Nature发表HER2/CD3/CD28三抗作用机制
2022-02-25
Nature：免疫治疗新突破，赛诺菲开发三特异性抗体，提高T细胞抗癌效果
2022-02-23
CDE新规加快创新药上市！恒瑞、强生、武田等90款产品谁将率先冲线？
2022-02-17
押注NK细胞疗法，Intellia与ONK达成超9亿美元合作，开发CRISPR基因编辑癌症细胞疗法
2022-02-08
回望创新药的2021：内卷之下，行业呼唤差异化创新
CytoCares
Technology Platform
Pipeline
Contact Us
COPYRIGHT@CytoCares 2022
Legal Statement
+86 021-50582090
info@ratdat.com
Follow WeChat
CytoCares
Technology Platform
Pipeline
Contact Us
Legal Statement
COPYRIGHT@CytoCares 2022.
